Why the study?
The molecular mechanisms triggered by impaired glucose and lipid metabolism that induce heart damage in diabetic cardiomyopathy remain unclear.
Does a high fat diet alter cardiac injury and mitochondrial dysfunction in a rat model of streptozocin-induced diabetic cardiomyopathy?
Does a high fat diet alter cardiac injury and mitochondrial dysfunction in a rat model of streptozocin-induced diabetic cardiomyopathy?
A high-fat diet paradoxically attenuates early cardiac dysfunction in a rat model of diabetic cardiomyopathy by inhibiting MMP-2 translocation into mitochondria.
High-fat diet attenuates early diabetic cardiomyopathy in rats; leaves open translation of MMP-2 mechanisms to human disease.
AIMS: Diabetic cardiomyopathy represents the main cause of death among diabetic people. Despite this evidence, the molecular mechanisms triggered by impaired glucose and lipid metabolism inducing heart damage remain unclear. The aim of our study was to investigate the effect of altered metabolism on the early stages of cardiac injury in experimental diabetes. METHODS: For this purpose, rats were fed a normocaloric diet (NPD) or a high fat diet (HFD) for up to 12 weeks. After the fourth week, streptozocin (35 mg/kg) was administered in a subgroup of both NPD and HFD rats to induce diabetes. Cardiac function was analysed by echocardiography. Matrix metalloproteinases (MMPs) activity and intracellular localization were assessed through zymography and immunofluorescence, whereas apoptotic and oxidative markers by immunohistochemistry and western blot. RESULTS: Hyperglycaemia or hyperlipidaemia reduced ejection fraction and fractional shortening as compared with control. Unexpectedly, cardiac dysfunction was less marked in diabetic rats fed a hyperlipidaemic diet, suggesting an adaptive response of the myocardium to hyperglycaemia-induced injury. This response was characterized by the inhibition of N-terminal truncated-MMP-2 translocation from endoplasmic reticulum into mitochondria and by superoxide anion overproduction observed in cardiomyocytes under hyperglycaemia. CONCLUSION: Overall, these findings suggest novel therapeutic targets aimed to counteract mitochondrial dysfunction in the onset of diabetic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Gliozzi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: